Advertisement
U.S. Markets open in 9 hrs 3 mins
S&P Futures
5,885.25 -11.00 (-0.19%) Dow Futures
43,113.00 -64.00 (-0.15%) Nasdaq Futures
20,465.75 -53.75 (-0.26%) Russell 2000 Futures
2,248.70 -6.80 (-0.30%) Crude Oil
70.43 -0.13 (-0.18%) Gold
2,748.80 +9.90 (+0.36%)
Intellia Therapeutics, Inc. (38I.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Follow
At close: 10:04AM CEST
| Previous Close | 19.19 |
| Open | 19.22 |
| Bid | 19.03 x 25000 |
| Ask | 19.14 x 25000 |
| Day's Range | 19.22 - 19.32 |
| 52 Week Range | 15.48 - 31.78 |
| Volume | |
| Avg. Volume | 214 |
| Market Cap | 1.962B |
| Beta (5Y Monthly) | 1.76 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.04 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 176.00 |
ZacksIntellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Intellia Therapeutics (NTLA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Motley FoolThis Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street
Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.